ArticleThe International journal of eating disorders2025
Validating Online Parent- and Self-Report Screening Methods for Avoidant/Restrictive Food Intake Disorder.
Article in The International journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Associations Between Avoidant/Restrictive Food Intake Disorder Dimensions and Obsessive-Compulsive Symptomatology.European eating disorders review : the journal of the Eating Disorders Association · 2026Article
- Prevalence of Avoidant/Restrictive Food Intake Disorder (ARFID) in children with and without food allergy.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026Article
- Co-Occurrence of Avoidant/Restrictive Food Intake Disorder (ARFID) and Schizophrenia-Spectrum Disorders: A Comprehensive Review.Journal of clinical medicine · 2026Review
- Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample.Autism research : official journal of the International Society for Autism Research · 2025Article
- Advancing the Science of Avoidant/Restrictive Food Intake Disorder (ARFID): Six Key Questions.The International journal of eating disorders · 2025Article
- Suicidal ideation and avoidant/restrictive food intake disorder: Findings from the ARFID-GEN study.Psychiatry research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveAlthough several assessments have been developed to diagnose or measure avoidant/restrictive food intake disorder (ARFID) symptoms, few studies have validated these tools in nonclinical and adult samples. This study explored the validity of two self- and parent/guardian-report ARFID screening measures in identifying adults and children who may have ARFID within a large community sample.
methodFifty participants (divided into two groups: 25 adults and 25 parents/guardians of children) were selected from the ARFID Genes and Environment study, which enrolled over 3000 adults and parents/guardians of children who screened positive for ARFID on either the Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire (PARDI-AR-Q) or the Nine Item ARFID Screen (NIAS) self- and parent/guardian-report measures. Participants then completed the ARFID portion of the Pica, ARFID, and Rumination Disorder Interview (PARDI) to determine ARFID diagnosis.
resultsCorrelations between the PARDI-AR-Q and PARDI (r = 0.31-0.67) were weaker than the correlations between the NIAS and PARDI (r = 0.53-0.64) in both groups. The diagnostic positive predictive value for the PARDI-AR-Q was numerically higher (adults = 55.0%; parents/guardians = 76.0%) than the NIAS (adults = 45.8%; parents/guardians = 64.0%). Most PARDI-AR-Q dimensions and all NIAS dimensions were significant predictors of their corresponding PARDI dimensions in both groups. DISCUSSION: The PARDI-AR-Q more accurately identified adults and children with ARFID, whereas the NIAS was a better estimator of ARFID symptoms. These findings provide partial support for using these self- and parent/guardian-report screeners. Results highlight the need to better understand diagnostic presentations of ARFID within community samples, particularly in adults, and to refine these tools within those populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.